Want to see IN:SUPRIYA full AI Analyst Report?
Supriya Lifescience Limited (SUPRIYA) Ratios
Supriya Lifescience Limited Ratios
IN:SUPRIYA's free cash flow for Q1 2027 was $0.00. For the 2027 fiscal year, IN:SUPRIYA's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.40 | 5.32 | 5.17 | 4.85 | 4.99 |
| Quick Ratio | 3.08 | 3.88 | 4.06 | 3.64 | 4.06 |
| Cash Ratio | 0.31 | 0.93 | 0.89 | 0.89 | 1.66 |
| Solvency Ratio | 1.49 | 1.80 | 1.27 | 0.84 | 1.36 |
| Operating Cash Flow Ratio | 1.61 | 2.10 | 1.47 | 0.69 | 0.49 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 242.11 | 3.98 | 2.29 |
| Net Current Asset Value | $ 3.73B | $ 3.21B | $ 2.92B | $ 3.44B | $ 3.78B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.01 | 0.03 | 0.04 |
| Debt-to-Equity Ratio | 0.00 | 0.01 | 0.01 | 0.03 | 0.04 |
| Debt-to-Capital Ratio | 0.00 | 0.01 | 0.01 | 0.03 | 0.04 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 |
| Financial Leverage Ratio | 1.13 | 1.12 | 1.13 | 1.17 | 1.19 |
| Debt Service Coverage Ratio | 126.74 | 124.61 | 53.87 | 5.24 | 6.52 |
| Interest Coverage Ratio | 140.62 | 142.56 | 75.74 | 37.39 | 48.16 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Interest Debt Per Share | 0.91 | 0.88 | 0.94 | 3.17 | 3.93 |
| Net Debt to EBITDA | -0.11 | -0.26 | -0.34 | -0.46 | -0.62 |
| Profitability Margins | |||||
| Gross Profit Margin | 54.21% | 55.18% | 49.14% | 62.11% | 55.74% |
| EBIT Margin | 33.42% | 35.92% | 29.42% | 27.75% | 40.71% |
| EBITDA Margin | 36.85% | 38.85% | 32.19% | 30.37% | 42.66% |
| Operating Profit Margin | 32.09% | 34.51% | 27.56% | 25.57% | 38.92% |
| Pretax Profit Margin | 33.19% | 35.68% | 29.05% | 27.38% | 39.90% |
| Net Profit Margin | 25.26% | 26.99% | 20.88% | 19.92% | 29.23% |
| Continuous Operations Profit Margin | 25.26% | 26.99% | 20.88% | 19.92% | 29.23% |
| Net Income Per EBT | 76.10% | 75.64% | 71.89% | 72.77% | 73.25% |
| EBT Per EBIT | 103.44% | 103.38% | 105.42% | 107.08% | 102.52% |
| Return on Assets (ROA) | 15.41% | 16.90% | 12.93% | 10.95% | 20.66% |
| Return on Equity (ROE) | 17.46% | 18.86% | 14.61% | 12.85% | 24.66% |
| Return on Capital Employed (ROCE) | 21.49% | 23.33% | 18.61% | 15.92% | 31.83% |
| Return on Invested Capital (ROIC) | 16.35% | 17.64% | 13.37% | 11.32% | 22.53% |
| Return on Tangible Assets | 15.42% | 16.92% | 12.95% | 10.97% | 20.70% |
| Earnings Yield | 4.62% | 3.19% | 4.16% | 5.85% | 3.82% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.77 | 5.15 | 4.88 | 4.92 | 4.26 |
| Payables Turnover | 3.42 | 4.19 | 6.06 | 2.82 | 4.69 |
| Inventory Turnover | 2.38 | 2.64 | 4.23 | 1.56 | 2.49 |
| Fixed Asset Turnover | 1.14 | 1.16 | 1.25 | 1.37 | 2.24 |
| Asset Turnover | 0.61 | 0.63 | 0.62 | 0.55 | 0.71 |
| Working Capital Turnover Ratio | 2.16 | 2.06 | 1.65 | 1.18 | 2.00 |
| Cash Conversion Cycle | 143.69 | 122.12 | 100.77 | 178.19 | 154.39 |
| Days of Sales Outstanding | 96.75 | 70.90 | 74.80 | 74.14 | 85.58 |
| Days of Inventory Outstanding | 153.65 | 138.39 | 86.23 | 233.70 | 146.57 |
| Days of Payables Outstanding | 106.72 | 87.17 | 60.25 | 129.66 | 77.75 |
| Operating Cycle | 250.41 | 209.29 | 161.03 | 307.85 | 232.15 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 24.25 | 21.44 | 14.08 | 8.22 | 6.06 |
| Free Cash Flow Per Share | 5.34 | 1.27 | -4.02 | -5.24 | -1.38 |
| Dividend Paid and CapEx Coverage Ratio | 1.22 | 1.02 | 0.75 | 0.58 | 0.76 |
| Capital Expenditure Coverage Ratio | 1.28 | 1.06 | 0.78 | 0.61 | 0.81 |
| Operating Cash Flow Coverage Ratio | 35.92 | 32.08 | 20.65 | 2.95 | 1.78 |
| Operating Cash Flow to Sales Ratio | 0.24 | 0.25 | 0.20 | 0.15 | 0.09 |
| Free Cash Flow Yield | 0.95% | 0.17% | -1.13% | -2.75% | -0.28% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 21.63 | 31.34 | 24.02 | 17.09 | 26.15 |
| Price-to-Sales (P/S) Ratio | 5.46 | 8.46 | 5.02 | 3.40 | 7.64 |
| Price-to-Book (P/B) Ratio | 3.78 | 5.91 | 3.51 | 2.19 | 6.45 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 105.21 | 578.14 | -88.46 | -36.37 | -357.58 |
| Price-to-Operating Cash Flow Ratio | 23.17 | 34.14 | 25.25 | 23.20 | 81.36 |
| Price-to-Earnings Growth (PEG) Ratio | 1.92 | 0.54 | 0.74 | -0.42 | 2.24 |
| Enterprise Value Multiple | 14.72 | 21.51 | 15.25 | 10.75 | 17.29 |
| Enterprise Value | 44.91B | 58.20B | 27.99B | 14.72B | 38.32B |
| EV to EBITDA | 14.72 | 21.51 | 15.25 | 10.75 | 17.29 |
| EV to Sales | 5.42 | 8.36 | 4.91 | 3.26 | 7.38 |
| EV to Free Cash Flow | 104.47 | 571.21 | -86.52 | -34.88 | -345.12 |
| EV to Operating Cash Flow | 23.00 | 33.73 | 24.70 | 22.25 | 78.52 |
| Tangible Book Value Per Share | 148.64 | 123.65 | 101.10 | 86.77 | 76.31 |
| Shareholders’ Equity Per Share | 148.80 | 123.83 | 101.31 | 86.91 | 76.50 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.24 | 0.24 | 0.28 | 0.27 | 0.27 |
| Revenue Per Share | 102.85 | 86.52 | 70.87 | 56.04 | 64.53 |
| Net Income Per Share | 25.98 | 23.35 | 14.80 | 11.16 | 18.86 |
| Tax Burden | 0.76 | 0.76 | 0.72 | 0.73 | 0.73 |
| Interest Burden | 0.99 | 0.99 | 0.99 | 0.99 | 0.98 |
| Research & Development to Revenue | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 |
| SG&A to Revenue | 0.22 | 0.09 | 0.04 | 0.04 | 0.03 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.93 | 0.92 | 0.95 | 0.54 | 0.24 |
Currency in INR
